Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avigen’s Argument With Largest Shareholder Emblematic Of Biotech Troubles

This article was originally published in The Pink Sheet Daily

Executive Summary

Biotechnology Value Fund wants the firm to accept a merger offer from MediciNova; Avigen wants more time to keep rolling the dice.

You may also be interested in...



MediciNova and Avigen Move One Step Closer To A Merger

Two months after unveiling a tentative framework for a merger, MediciNova and Avigen hammer out an agreement that gives MediciNova ownership of Avigen's remaining assets for a song.

MediciNova and Avigen Move One Step Closer To A Merger

Two months after unveiling a tentative framework for a merger, MediciNova and Avigen hammer out an agreement that gives MediciNova ownership of Avigen's remaining assets for a song.

Avigen Board Survives Proxy Fight But Company Will Liquidate Holdings

In abandoning its efforts to find a buyer, troubled biotech promises shareholders a return of at least $1.20 per share.

Topics

UsernamePublicRestriction

Register

LL016789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel